Skip to content

Public FDA record

Z-0239-04: DrugCheck 5, in-vitro diagnostic test for drugs of abuse: AMP, COC, THC, OPI, MET.

Recall record Z-0239-04 for Drug Free Enterprises Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0239-04
Company in FDA record
Drug Free Enterprises Inc
FDA classification date
Dec 18, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Lacks professional use labeling and firm name and address.

Source facts

Action
Firm sent letters and stickers to customers in April 2003 asking them to overlabel existing stocks and to tell the firm how many were overlabeled. Recall is complete.
Initiated
2003-03-20
Root cause
Other
Terminated
2003-12-17
Distribution
Nationwide.
Recall number
Z-0239-04
Recall status
Terminated
CDRH record ID
30567
FDA classified
2003-12-18
Recall event number
27817

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗